CClinicalTrials.gg
CompletedNCT04249895Updated Dec 17, 2021

Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO )

An observational study in All Cancer, sponsored by Tata Medical Center. Completed at 1 site in India. Per ClinicalTrials.gov, last updated 2021-12-17.

Sponsored by Tata Medical Center · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
500
Sex
All
01

Study summary

In this pilot project Investigators propose to create annotated image data bank of patients suffering from cancer. The system will provide India's first comprehensive platform to upload annotated images with associated medical and demographic information of a patient. It will support flexible query from the users with appropriate choice from a set of attributes and design of various query filters using a GUI. Over the proposed period of 18 months, images and records related to radiation oncology including pretreatment images of at least 500 patients would be annotated and archived in the data bank. The imaging modalities to be covered are X-RAY mammograms, SPECT, CT, CBCT, MR, PET-CT, Ultrasound, digital histopathology, etc. In this phase, this study will include data sets of five types of cancers namely, breast, head and neck, brain, cervix and lung cancer.

Investigator propose to demonstrate the application of this data set in cancer research. Investigator will work on serial PET-CT based radiomics of breast and cervix cancer patients to extract appropriate features and correlate them with clinico-pathological variants.

02

Conditions studied

  • All Cancer

Browse trials for

Keywords

  • Carcinoma
  • Radiomics
  • Image Processing
  • Radiology
  • Molecular Biology
  • Data Analytics Center
  • Artificial Intelligence
  • Medical Physics
  • Big Data
  • Radiation Oncology
03

In context

Neoplasms

9,371 studies on the registry are indexed under Neoplasms; 2,492 are open to participants now.

This study's enrollment of 500 is above the median of 205 across 1,684 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Tata Medical Center is the lead sponsor of 10 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All Patients undergoing radiotherapy in the dept of radiotherapy, Tata Medical Center.

Inclusion criteria

  1. Patients undergoing radiotherapy planned with volumetric imaging.

Exclusion criteria

-

Exclusion Criteria:

  • Informed Consent not given
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
500 participants (actual)
Patient registry
No

Groups and cohorts

  • Main Cohort

    All patients are undergoing radiotherapy in Tata Medical Center

06

What researchers measure

Primary outcomes

  1. Number of patients with complete data safe.

    Count of patients with complete radiological, pathological and demographic information in the CHAVI RO database.

    Time frame: 18 months

07

Study locations

1 site
  • Sanjoy Chatterjee
    Kolkata, West Bengal 700160, India
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04249895
Lead sponsor
Tata Medical Center
Responsible party
Sponsor
First posted
Jan 31, 2020
Start date
Aug 31, 2018
Primary completion
Feb 28, 2021
Completion
Feb 28, 2021
Last update
Dec 17, 2021

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion